CIK 0000072444
- Accelerated filer
- Smaller reporting company
Vaxart, Inc.
Sign in to watch- Ticker
- VXRT
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 591212264
- Phone
- +1 650-550-3500
- Business address
- 310 UTAH AVENUE, SUITE 150, SOUTH SAN FRANCISCO, CA
- Former names
- Aviragen Therapeutics, Inc., Biota Pharmaceuticals, Inc., NABI BIOPHARMACEUTICALS, NABI BIOPHARMACEUTICALS, NABI /DE/, NORTH AMERICAN BIOLOGICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2006-11-03 | Third Point LLC | Purchase | +27,342 | $6.25 | $171K | 5,777,342 |
| 2006-11-03 | Third Point LLC | Sale | −27,342 | $6.22 | $170K | 5,750,000 |
| 2006-06-12 | Siegel Jordan I Sr. VP, Fin, CFO, CAO & Treas. | Grant or award | +60,000 | 60,000 | ||
| 2006-06-12 | Siegel Jordan I Sr. VP, Fin, CFO, CAO & Treas. | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2006-05-31 | RASMUSSEN HENRIK S MD Sr. VP Clin. Med. & Reg. Affs. | Other acquisition | +3,573.39 | $2.73 | $10K | 84,262.44 |
| 2006-05-31 | MCLAIN THOMAS H Chairman, CEO & President | Other acquisition | +4,764.52 | $2.73 | $13K | 127,021.8 |
| 2006-05-31 | FAHIM RAAFAT E F Sr. VP Tech. & Prod. | Other acquisition | +4,764.52 | $2.73 | $13K | 95,076.95 |
| 2006-05-17 | HARVEY RICHARD A JR Director | Grant or award | +7,500 | $6.19 | $46K | 30,996 |
| 2006-05-17 | HARVEY RICHARD A JR Director | Exercise or conversion · Stock Option (right to buy) | −7,500 | 0 | ||
| 2006-05-17 | COX GEOFFREY F Director | Grant or award | +5,250 | $6.19 | $32K | 23,771 |
| 2006-05-17 | COX GEOFFREY F Director | Exercise or conversion · Stock Option (right to buy) | −5,250 | 2,250 | ||
| 2006-05-12 | SUDOVAR STEPHEN Director | Grant or award | +4,365 | $6.30 | $27K | 8,362 |
| 2006-05-12 | SUDOVAR STEPHEN Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2006-05-12 | RASMUSSEN HENRIK S MD Sr. VP Clin. Med. & Reg. Affs. | Grant or award | +40,000 | 80,689.05 | ||
| 2006-05-12 | MCLAIN THOMAS H Chairman, CEO & President | Grant or award | +20,000 | 122,257.27 | ||
| 2006-05-12 | MCLAIN THOMAS H Chairman, CEO & President | Grant or award · Stock Option (right to buy) | +75,000 | 75,000 | ||
| 2006-05-12 | Logal Adam Interim CFO, CAO and Treasurer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2006-05-12 | Johnson Joseph Sr. VP, HR, IT, Bus. Strat. | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2006-05-12 | JENCKES LINDA Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 | ||
| 2006-05-12 | COX GEOFFREY F Director | Grant or award · Stock Option (right to buy) | +12,000 | 12,000 |
Page 40 of 42 · 830 trades